Tag: Erlinda Gordon
Epeius Biotech Reports Dose-Dependent Efficacy and Survival Benefits, Efficacy of Rexin-G in Metastatic Pancreas Cancer
SAN MARINO, Calif. -- Epeius Biotechnologies (www.epeiusbiotech.com) confirms the first real breakthrough for pancreatic cancer seen in years; publishes a landmark report of tumor-targeted...
Tumor-targeted REXIN-G Quells Metastatic Osteosarcoma, Prostate Cancer, and Pancreas Cancer as Stand-alone Therapy
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so...
Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival
SAN MARINO, Calif. -- Epeius Biotechnologies (www.epeiusbiotech.com) stuns the medical and scientific communities with a dramatic demonstration of single-agent efficacy with its lead product,...
The World's Smallest Hero! Epeius Bio's Rexin-G, Targeted Therapy for Metastatic Cancers
SAN MARINO, Calif. -- Epeius Biotechnologies' Rexin-G® is the world's smallest hero (epeiusbiotech.com). Imagine if you will, a tiny particle that can travel freely...
Epeius' Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma
SAN MARINO, Calif. -- Epeius Biotechnologies (www.epeiusbiotech.com) today announced the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out...
